Wall motion score index and ejection fraction for risk stratification after acute myocardial infarction.

[1]  J. Hoorntje,et al.  Comparison of radionuclide angiography with three echocardiographic parameters of left ventricular function in patients after myocardial infarction , 1998, The International Journal of Cardiac Imaging.

[2]  B. Pitt,et al.  Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[3]  D. Mele,et al.  Impact of tissue harmonic imaging in patients with distorted left ventricles: improvement in accuracy and reproducibility of visual, manual and automated echocardiographic assessment of left ventricular ejection fraction. , 2003, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[4]  W. O’Neill,et al.  Myocardial contrast echocardiography is superior to other known modalities for assessing myocardial reperfusion after acute myocardial infarction , 2003, Heart.

[5]  R. Senior,et al.  A prospective comparison of echocardiographic wall motion score index and radionuclide ejection fraction in predicting outcome following acute myocardial infarction , 2001, Heart.

[6]  V. Roger,et al.  Prognostic value of exercise echocardiography in 2,632 patients > or = 65 years of age. , 2001, Journal of the American College of Cardiology.

[7]  J S Alpert,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.

[8]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[9]  A. Weyman,et al.  Echocardiographic determinants of left ventricular ejection fraction after acute myocardial infarction. , 2000, American heart journal.

[10]  E. Carluccio,et al.  Usefulness of the severity and extent of wall motion abnormalities as prognostic markers of an adverse outcome after a first myocardial infarction treated with thrombolytic therapy. , 2000, The American journal of cardiology.

[11]  M. Domanski,et al.  Comparison of echocardiography and radionuclide angiography as predictors of mortality in patients with left ventricular dysfunction (studies of left ventricular dysfunction). , 1999, The American journal of cardiology.

[12]  L. Køber,et al.  Long-term prognostic importance of hyperkinesia following acute myocardial infarction , 1999 .

[13]  G. Lamas,et al.  Ejection fraction by radionuclide ventriculography and contrast left ventriculogram. A tale of two techniques. SAVE Investigators. Survival and Ventricular Enlargement. , 1999, Journal of the American College of Cardiology.

[14]  J. Seward,et al.  Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. , 1998, Circulation.

[15]  M. Jensen-Urstad,et al.  Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy. , 1998, The American journal of cardiology.

[16]  J B Seward,et al.  Echocardiographic assessment of left ventricular remodeling: are left ventricular diameters suitable tools? , 1997, Journal of the American College of Cardiology.

[17]  P J Lynch,et al.  Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. , 1996, The American journal of cardiology.

[18]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[19]  K. Oldroyd,et al.  Do radionuclide and echocardiographic techniques give a universal cut off value for left ventricular ejection fraction that can be used to select patients for treatment with ACE inhibitors after myocardial infarction? , 1995, British heart journal.

[20]  L. Køber,et al.  An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). TRAndolapril Cardiac Evaluation. , 1994, European heart journal.

[21]  G. Lamas,et al.  Quantitative Two-Dimensional Echocardiographic Measurements are Major Predictors of Adverse Cardiovascular Events After Acute Myocardial Infarction: The Protective Effect of Captopril , 1994, Circulation.

[22]  E. Negri,et al.  Determinants of 6‐Month Mortality in Survivors of Myocardial Infarction After Thrombolysis Results of the GISSI‐2 Data Base , 1993, Circulation.

[23]  H Feigenbaum,et al.  Low‐Dose Dobutamine Echocardiography Detects Reversible Dysfunction After Thrombolytic Therapy of Acute Myocardial Infarction , 1993, Circulation.

[24]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[25]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[26]  D. Koshland.  A tale of two techniques. , 1988, Science.

[27]  C. Visser,et al.  Prognostic implications of regional hyperkinesia and remote asynergy of noninfarcted myocardium. , 1986, The American journal of cardiology.

[28]  J. Fleiss,et al.  Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.